NOTE PURCHASE AGREEMENTNote Purchase Agreement • October 28th, 2024 • Panbela Therapeutics, Inc. • Pharmaceutical preparations • California
This Note Purchase Agreement, dated as of October 22, 2024 (this “Agreement”), is entered into by and among PANBELA THERAPEUTICS INC., a Delaware corporation (the “Company”), and NANT CAPITAL, LLC, a Delaware limited liability company (the “Investor”).
CONTINUING GUARANTYContinuing Guaranty • October 28th, 2024 • Panbela Therapeutics, Inc. • Pharmaceutical preparations • California
FOR VALUE RECEIVED, the sufficiency of which is hereby acknowledged, and in consideration of credit and/or financial accommodation heretofore or hereafter from time to time made or granted to PANBELA THERAPEUTICS, INC. (the “Borrower”) by NANT CAPITAL, LLC and its successors and assigns (collectively the “Lender”), the undersigned Guarantor (whether one or more the “Guarantor”, and if more than one jointly and severally) hereby furnishes its guaranty of the Guaranteed Obligations (as hereinafter defined) as follows:
